David Scott Miller


AuthID: R-00K-250

Publications Requiring Validation

1
TITLE: Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775
AUTHORS: Vicky Makker; Nicoletta Colombo; Antonio Casado; Alessandro D Santin; Emeline Colomba; David Scott Miller; Keiichi Fujiwara; Sandro Pignata; Kan Yonemori; Yong Man Kim; Sally Baron-Hay; Isabelle Ray-Coquard; Ronnie Shapira-Frommer; Rebecca Kristeleit; Shin Nishio; Shiro Suzuki; Eva M Guerra Alía; Ulus A Sanli; Frederic Selle; Ayumi Shikama; Jorge L Martínez Rodríguez; Zafer Arik; Ali Arican; Alexandra Sebastianelli; Zhou Yu; Jodi McKenzie; Stephan Kruger; Robin Meng; Chinyere E Okpara; Domenica Lorusso; ...More
PUBLISHED: 2026, SOURCE: Journal for ImmunoTherapy of Cancer, VOLUME: 14, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
2
TITLE: Impact of interruptions in chemotherapy on survival for patients with metastatic or recurrent cervical cancer.
AUTHORS: Risha Sinha; Arianna Portmann; Christopher A Walker; Steven Blaine Holloway; Elizabeth C Stock; David Scott Miller; Lesley Brianne Conrad; James L Wilder; Devin E Jones; Jayanthi Sivasothy Lea;
PUBLISHED: 2025, SOURCE: Journal of Clinical Oncology, VOLUME: 43, ISSUE: 16_suppl
INDEXED IN: CrossRef
IN MY: ORCID
3
TITLE: Impact of interruptions in chemotherapy on survival for patients with metastatic or recurrent cervical cancer
AUTHORS: Risha Sinha; Arianna Portmann-Baracco; April R Gorman; Elizabeth C Stock; Steven B Holloway; David Scott Miller; Jayanthi Lea;
PUBLISHED: 2025
INDEXED IN: CrossRef
IN MY: ORCID

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service